<DOC>
	<DOCNO>NCT02050841</DOCNO>
	<brief_summary>The purpose study investigate safety , tolerability efficacy octaplas pediatric patient require replacement multiple coagulation factor . Replacement multiple coagulation factor pediatric patient acquire deficiency due liver disease pediatric patient require cardiac surgery liver surgery .</brief_summary>
	<brief_title>Octaplas Pediatric Plasma Replacement Trial</brief_title>
	<detailed_description />
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>1 . Patient require liver cardiac surgery and/or patient liver dysfunction associate coagulopathy replacement multiple coagulation factor require . 2 . Voluntarily give , write sign informed consent patient 's legal representative ( ) guardian ( ) . Children deem old enough Investigator/institution understand risk benefit study also make aware risks/benefits study provide write assent . 3 . Male female patient â‰¤ 16 year age . 1 . Patient know homozygous congenital deficiency protein S. 2 . Patient history hypersensitivity reaction blood plasmaderived product excipient investigational product . 3 . Patient already know IgA deficiency document antibody IgA . 4 . Patient congenital factor deficiency platelet disorder require plasma treatment . 5 . Patient currently participate another study investigate new drug product another interventional clinical study may impact coagulation factor participate last three ( 3 ) month . 6 . Patient receive FFP , FP24 plasma product Octaplas within last 72 hour ( cryoprecipitate albumin exclusionary ) prior first Octaplas infusion . 7 . Patient ECMO ( Extracorporeal Membrane Oxygenation ) plasma order treat physician first infusion episode . 8 . Patient pregnant . 9 . Patient predict require massive blood transfusion define 40 mL per kilogram blood product 24hour period 10 . Patient receive plasma exchange , therapeutic plasma exchange ( TPE ) plasmapheresis . 11 . Patient premature neonate define less 37 week gestation . 12 . Cardiac surgery patient develop need plasma replacement great 72 hour end associate cardiac surgery coagulopathy due hepatic dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>patient</keyword>
	<keyword>replacement</keyword>
	<keyword>coagulation factor</keyword>
	<keyword>plasma</keyword>
	<keyword>s/d plasma</keyword>
	<keyword>Octaplas</keyword>
	<keyword>plasma replacement</keyword>
</DOC>